This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
Drug to cut heart attacks tested
A preliminary study of 1,400 men using Atromid S, marketed as Clofibate, shows fewer first heart attacks in treated men versus controls. Krasno urged federal funding for broader trials, while Cooper warned against rapid national testing. Costly long term therapy ranges from 102 to 365 dollars annually.
MENTIONED IN THIS ARTICLE
New York
Louis R. Krasno
United Air Lines
Senate Appropriations Committee
San Francisco
Krasno
Senate
National Heart Institute
Theodore Cooper
Manhattan
Mary Lasker